Research Briefing from the Global Conference on Myositis (GCOM)
What’s next in myositis treatment—and what are the latest clinical trials revealing?
The Myositis Association (TMA) and the Myositis Clinical Trials Consortium (MCTC) are partnering together to present this special webinar kicking off Myositis Awareness Month called Research Briefing from the Global Conference on Myositis (GCOM). This leading scientific conference, held every two years, convenes March of 2026 in Lisbon, Portugal, bringing together experts from around the world to share the newest advances in myositis research and care.
In this exclusive briefing moderated by Edoardo Conticini, MD, PhD, a rheumatologist at the University of Siena, Italy, two distinguished physicians will present key takeaways from the conference:
Shiri Keret, MD – Assistant Professor of Medicine and Head of the Myositis Clinic in the Rheumatology Unit at Bnai-Zion Medical Center, Faculty of Medicine, Technion – Israel Institute of Technology (Israel), presenting on “Novel Treatments in Myositis.”
Jisna Paul, MBBS, RhMSUS, FACR – Clinical Associate Professor of Internal Medicine and Rheumatology and Co-Director of the comprehensive Myositis Clinic at The Ohio State University Wexner Medical Center (USA), presenting on “Updates from Recent Clinical Trials in IBM, DM, and Other Forms of Myositis”.
